(NASDAQ: QURE) Uniqure Nv's forecast annual revenue growth rate of 140.27% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 109.05%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.77%.
Uniqure Nv's revenue in 2025 is $14,337,000.On average, 15 Wall Street analysts forecast QURE's revenue for 2025 to be $1,007,850,637, with the lowest QURE revenue forecast at $367,224,362, and the highest QURE revenue forecast at $1,549,716,438. On average, 15 Wall Street analysts forecast QURE's revenue for 2026 to be $3,317,638,656, with the lowest QURE revenue forecast at $569,957,669, and the highest QURE revenue forecast at $8,751,275,335.
In 2027, QURE is forecast to generate $12,352,740,620 in revenue, with the lowest revenue forecast at $5,887,221,589 and the highest revenue forecast at $20,700,744,020.